Jenny Freeman
Direttore/Membro del Consiglio presso SENZIME AB
Patrimonio netto: 203 259 $ in data 30/04/2024
Profilo
Jenny E.
Freeman was the founder of Respiratory Motion, Inc. (founded in 2010) and JEF Core, Inc. (founded in 2007) where she holds the titles of Director and President respectively.
Dr. Freeman is also the founder of Cheirologic Partners, Inc. Dr. Freeman's current job is as a Director at Senzime AB since 2022.
Dr. Freeman's former jobs include being the President & Chief Executive Officer at HyperMed, Inc., and holding positions as Principal at Sumitomo Pharma America, Inc. and Argose, Inc. Dr. Freeman's education includes an undergraduate degree from Yale University in 1975 and a doctorate degree from New York University in 1979.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
SENZIME AB
0.32% | 30/12/2022 | 318 707 ( 0.32% ) | 203 259 $ | 30/04/2024 |
Posizioni attive di Jenny Freeman
| Società | Posizione | Inizio |
|---|---|---|
| SENZIME AB | Direttore/Membro del Consiglio | 01/01/2022 |
Respiratory Motion, Inc.
 Respiratory Motion, Inc. Medical SpecialtiesHealth Technology Respiratory Motion, Inc. develops medical devices. The firm specializes in clinical research, clinical evaluation and testing. Its product ExSpiron 1Xi, measures minute ventilation non-invasively. The company was founded by Jenny E. Freeman, Alexander Panasyuk and Svetlana Panasyuk in March 2010 and is headquartered in Waltham, MA. | Amministratore Delegato | 01/03/2010 |
| Cheirologic Partners, Inc. | Fondatore | - |
Precedenti posizioni note di Jenny Freeman
| Società | Posizione | Fine |
|---|---|---|
JEF Core, Inc.
 JEF Core, Inc. Investment ManagersFinance Headquartered in Weston, Massachusetts, JEF Core, Inc., formerly Cheirologic Partners, Inc. is a research firm covering the health technology sector. | Fondatore | 01/01/2010 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | - |
| Argose, Inc. | Corporate Officer/Principal | - |
HyperMed, Inc.
 HyperMed, Inc. Medical DistributorsDistribution Services HyperMed, Inc. develops medical imaging devices. The firm provides its services to the vascular surgeons, vascular laboratories, foot and ankle surgeons, podiatrists, research organizations, and educational institutions. The company was founded in 1997 and is headquartered in Burlington, MA. | Presidente | - |
Formazione di Jenny Freeman
| Yale University | Undergraduate Degree |
| New York University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SENZIME AB | Health Technology |
| Aziende private | 6 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Respiratory Motion, Inc.
Respiratory Motion, Inc. Medical SpecialtiesHealth Technology Respiratory Motion, Inc. develops medical devices. The firm specializes in clinical research, clinical evaluation and testing. Its product ExSpiron 1Xi, measures minute ventilation non-invasively. The company was founded by Jenny E. Freeman, Alexander Panasyuk and Svetlana Panasyuk in March 2010 and is headquartered in Waltham, MA. | Health Technology |
JEF Core, Inc.
JEF Core, Inc. Investment ManagersFinance Headquartered in Weston, Massachusetts, JEF Core, Inc., formerly Cheirologic Partners, Inc. is a research firm covering the health technology sector. | Finance |
HyperMed, Inc.
HyperMed, Inc. Medical DistributorsDistribution Services HyperMed, Inc. develops medical imaging devices. The firm provides its services to the vascular surgeons, vascular laboratories, foot and ankle surgeons, podiatrists, research organizations, and educational institutions. The company was founded in 1997 and is headquartered in Burlington, MA. | Distribution Services |
| Argose, Inc. | |
| Cheirologic Partners, Inc. |
- Borsa valori
- Insiders
- Jenny Freeman